Skip to main content
. 2021 Apr;19(4):538–552. doi: 10.2174/1570159X18666200529151741

Fig. (5).

Fig. (5)

Results of the meta-analysis of the evaluation of inappropriate speech in the ABC scale on treatment with risperidone: (A) short-term (until up 8 weeks); (B) long-term (after 8 weeks); (C) versus placebo. Confidence Interval (CI), Heterogeneity (I2) and heterogeneity’s p-value (p).